Have Insiders Sold Vicarious Surgical Shares Recently? \

We note that the Vicarious Surgical Inc. (NYSE:RBOT) Co-Founder, Adam Sachs, recently sold US$54k worth of stock for US$2.24 per share. It might not be a huge sale, but it did reduce their holding size 11%, hardly encouraging.

See our latest analysis for Vicarious Surgical

The Last 12 Months Of Insider Transactions At Vicarious Surgical

Over the last year, we can see that the biggest insider purchase was by insider Philip Liang for US$241k worth of shares, at about US$3.05 per share. That means that an insider was happy to buy shares at above the current price of US$2.19. Their view may have changed since then, but at least it shows they felt optimistic at the time. We always take careful note of the price insiders pay when purchasing shares. As a general rule, we feel more positive about a stock when an insider has bought shares at above current prices, because that suggests they viewed the stock as good value, even at a higher price. Philip Liang was the only individual insider to buy shares in the last twelve months. Notably Philip Liang was also the biggest seller.

Philip Liang purchased 730.33k shares over the year. The average price per share was US$2.47. The chart below shows insider transactions (by companies and individuals) over the last year. If you want to know exactly who sold, for how much, and when, simply click on the graph below!

There are always plenty of stocks that insiders are buying. So if that suits your style you could check each stock one by one or you could take a look at this free list of companies. (Hint: insiders have been buying them).

Insider Ownership Of Vicarious Surgical

I like to look at how many shares insiders own in a company, to help inform my view of how aligned they are with insiders. We usually like to see fairly high levels of insider ownership. Vicarious Surgical insiders own about US$56m worth of shares. That equates to 20% of the company. This level of insider ownership is good but just short of being particularly stand-out. It certainly does suggest a reasonable degree of alignment.

So What Does This Data Suggest About Vicarious Surgical Insiders?

It is good to see the recent insider purchase. We also take confidence from the longer term picture of insider transactions. But on the other hand, the company made a loss during the last year, which makes us a little cautious. Given that insiders also own a fair bit of Vicarious Surgical we think they are probably pretty confident of a bright future. In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing Vicarious Surgical. Every company has risks, and we've spotted 4 warning signs for Vicarious Surgical (of which 2 are potentially serious!) you should know about.

If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, that have HIGH return on equity and low debt.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.